Breaking News Instant updates and real-time market news.

EL

Estee Lauder

$106.92

-1.6 (-1.47%)

, EBIX

Ebix

$60.40

1.05 (1.77%)

10:38
09/28/17
09/28
10:38
09/28/17
10:38

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Estee Lauder (EL) initiated with a Neutral at DA Davidson. 2. Ebix (EBIX) initiated with an Outperform at William Blair. 3. Lear (LEA) initiated with a Buy at Jefferies. 4. Vistra Energy (VST) initiated with a Buy at Citi. 5. MediWound (MDWD) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

EL

Estee Lauder

$106.92

-1.6 (-1.47%)

EBIX

Ebix

$60.40

1.05 (1.77%)

LEA

Lear

$173.72

1.03 (0.60%)

VST

Vistra Energy

$18.74

0.04 (0.21%)

MDWD

MediWound

$4.90

-0.1 (-2.00%)

  • 25

    Oct

  • 30

    Oct

EL Estee Lauder
$106.92

-1.6 (-1.47%)

09/20/17
OPCO
09/20/17
NO CHANGE
Target $120
OPCO
Outperform
Estee Lauder price target raised to $120 from $110 at Oppenheimer
Oppenheimer analyst Rupesh Parikh raised his price target for Estee Lauder to $120 from $110, citing a strengthening fundamental outlook in a slowing consumer staples backdrop. The analyst still sees the case for outperformance going forward, and reiterates an Outperform rating on the shares and Estee Lauder as his top pick.
09/27/17
DADA
09/27/17
INITIATION
Target $115
DADA
Neutral
Estee Lauder initiated with a Neutral at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Estee Lauder with a Neutral rating and a $115 price target, citing the stock's 42% increase since December 2016, and saying the stock price reflects current fundamentals.
09/07/17
JEFF
09/07/17
NO CHANGE
Target $122
JEFF
Buy
Estee Lauder price target raised to $122 from $112 at Jefferies
Jefferies analyst Stephanie Wissink raised her price target for Estee Lauder shares to $122 and keeps a Buy rating on the shares. Growing adoption of the company's brands within specialty multi environments is a signal that its positioning strategies are taking hold, Wissink tells investors in a research note following channel checks. She believes Estee Lauder's travel retail merchandise improvements and introduction of mid-sized brands should drive a slightly higher rate of growth than previously assumed.
09/28/17
GSCO
09/28/17
UPGRADE
Target $135
GSCO
Conviction Buy
Philip Morris upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Philip Morris (PM) to Conviction Buy and reiterates the stock as her top pick in within tobacco. The company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products, Hong tells investors in a research note where she also upgraded Brown-Forman (BF.B) to Neutral. The analyst views Philip Morris' IQOS as a "game-changer for Global Tobacco." She raised her price target for the shares to $135 from $133. Hong also highlights Mondelez (MDLZ), Estee Lauder (EL) and Kimberly-Clark (KMB) as top multinational picks.
EBIX Ebix
$60.40

1.05 (1.77%)

09/27/17
WBLR
09/27/17
INITIATION
WBLR
Outperform
Ebix initiated with an Outperform at William Blair
03/01/17
CHLM
03/01/17
NO CHANGE
Target $75
CHLM
Buy
Ebix price target raised to $75 from $68 at Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee raised his price target for Ebix to $75 from $68 after the company put up "another strong quarter," beating top and bottom line by a wide margin and posting "tremendous" free cash flow. The analyst continues to see a "very long runway" in front of the company to continue running the same playbook. He reiterates a Buy rating on the shares.
02/21/17
SIDC
02/21/17
INITIATION
Target $80
SIDC
Buy
Ebix initiated with a Buy at Sidoti (Friday)
Sidoti analyst Allen Klee initiated Friday shares of Ebix with a Buy rating and $80 price target.
09/28/17
WBLR
09/28/17
INITIATION
WBLR
Outperform
Ebix initiated with an Outperform at William Blair
William Blair analyst Adam Klauber last night started Ebix with an Outperform rating saying the company is well positioned for the "insurance technology wave." He believes the company has developed a successful strategy for gaining critical mass in key insurance technology markets.
LEA Lear
$173.72

1.03 (0.60%)

09/28/17
JEFF
09/28/17
INITIATION
Target $197
JEFF
Buy
Lear initiated with a Buy at Jefferies
Jefferies analyst David Kelley started Lear Corp. with a Buy rating and $197 price target. The analyst views the company as a "solid legacy supplier play" with Seating gaining market share.
09/26/17
BUCK
09/26/17
DOWNGRADE
BUCK
Neutral
Lear downgraded to Neutral on valuation at Buckingham
Buckingham analyst Joseph Amaturo downgraded Lear to Neutral due to valuation and maintained a $175 price target.
09/26/17
BUCK
09/26/17
DOWNGRADE
BUCK
Neutral
Lear downgraded to Neutral from Buy at Buckingham
09/25/17
COWN
09/25/17
INITIATION
Target $195
COWN
Outperform
Lear initiated with an Outperform at Cowen
Cowen analyst Jeffrey Osborne initiated Lear with an Outperform rating and $195 price target as he likes its positioning due to its E-Systems segment and sees continued content per vehicle growth in seating as well. He also likes its sum-of-the-parts valuation.
VST Vistra Energy
$18.74

0.04 (0.21%)

06/20/17
SBSH
06/20/17
NO CHANGE
SBSH
Citi sees increasing likelihood of Vistra acquiring Dynegy
After hosting investor meetings with managements in Texas, Citi analyst Praful Mehta believes the likelihood of a Dynegy (DYN) acquisition by Vistra Energy (VST) is increasing. He views price as the "likely gating item" and continues to expect an $11-$12 per share buyout price for Dynegy in an all stock deal. Vistra management seems "more open to the deal than we originally interpreted," Mehta tells investors in a research note. The analyst also believes a private equity exit for Calpine (CPN) is increasing likely as the company continues with its reported sale process.
09/20/17
FBCO
09/20/17
INITIATION
Target $20
FBCO
Outperform
Vistra Energy initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Weinstein started Vistra Energy with an Outperform rating and $20 price target. The analyst sees the business as "favorably balanced" with support from a high-margin retailing business.
09/28/17
SBSH
09/28/17
INITIATION
Target $22
SBSH
Buy
Vistra Energy initiated with a Buy at Citi
Citi analyst Praful Mehta started Vistra Energy (VST) with a Buy rating and $22 price target. The company's "strong" retail business is supported by its "strong" generation footprint, the analyst contends. He expects Vistra will likely acquire Dynegy (DYN) in an all stock deal at $11-$12 per share, representing a "win-win" for both shareholder groups. Mehta pegs acquisition upside for Vistra shareholders at $3 per share.
06/08/17
LEHM
06/08/17
INITIATION
Target $16
LEHM
Equal Weight
Vistra Energy initiated with an Equal Weight at Barclays
Barclays analyst Daniel Ford started Vistra Energy with an Equal Weight rating and $16 price target.
MDWD MediWound
$4.90

-0.1 (-2.00%)

06/26/17
RHCO
06/26/17
NO CHANGE
RHCO
MediWound price target raised to $10 from $8 at SunTrust
SunTrust analyst Bruce Nudell raised his price target on MediWound after the company announced that the U.S. Biomedical Advanced Research and Development Authority, or BARDA, had indicated that it would exercise an option to fund the expansion of the company's NexoBrid indication. Nudell says that the cash the company looks set to receive from BARDA reduces its financial risk, while the exercise of the option would "modestly" lower the risk of NexoBrid. Nudell keeps a Buy rating on the stock.
11/28/16
AGIS
11/28/16
INITIATION
Target $11
AGIS
Buy
MediWound initiated with a Buy at Aegis
Aegis analyst Jason Wittes initiated MediWound with a Buy and an $11 price target.
09/28/17
COWN
09/28/17
INITIATION
Target $9
COWN
Outperform
MediWound initiated with an Outperform at Cowen
Cowen analyst Joshua Jennings initiated MediWound with an Outperform rating as he believes the company has two best-in-class debridement agents in Nexobrid and EscharEx. He believes the products should prove their value over the coming years, which will establish it as a truly novel tissue technology company. Jennings has a $9 price target on MediWound shares.
11/28/16
11/28/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson Controls (JCI) initiated with a Buy at Citi. 2. Red Hat (RHT) initiated with a Buy at Rosenblatt. 3. Ashland (ASH) reinstated with a Buy at Deutsche Bank. 4. MediWound (MDWD) initiated with a Buy at Aegis. 5. YY (YY) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SYNT

Syntel

$24.30

5.2 (27.23%)

20:37
10/17/17
10/17
20:37
10/17/17
20:37
Upgrade
Syntel rating change at William Blair »

Syntel upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 14

    Dec

QD

Qudian

20:35
10/17/17
10/17
20:35
10/17/17
20:35
Syndicate
Qudian 37.5M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ABT

Abbott

$55.06

0.43 (0.79%)

, USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

20:25
10/17/17
10/17
20:25
10/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$55.06

0.43 (0.79%)

USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

SVU

Supervalu

$19.38

0.57 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 17

    Jan

UNH

UnitedHealth

$203.89

10.69 (5.53%)

19:58
10/17/17
10/17
19:58
10/17/17
19:58
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

19:25
10/17/17
10/17
19:25
10/17/17
19:25
Conference/Events
The Heritage Foundation hosts President Trump »

President Trump speaks at…

SINA

Sina

$114.26

-0.73 (-0.63%)

19:18
10/17/17
10/17
19:18
10/17/17
19:18
Hot Stocks
Aristeia: Sina claims 'inaccurate' and 'misleading' »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLDR

Cloudera

$15.51

0.13 (0.85%)

, HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

18:57
10/17/17
10/17
18:57
10/17/17
18:57
Hot Stocks
Cloudera, Hitachi form strategic partnership »

Cloudera (CLDR) announced…

CLDR

Cloudera

$15.51

0.13 (0.85%)

HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$65.15

-1.15 (-1.73%)

18:35
10/17/17
10/17
18:35
10/17/17
18:35
Earnings
Pinnacle Financial reports Q3 adjusted EPS 90c, consensus 74c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial sees FY17 loans & deposits growth mid to high single digits »

Sees FY17 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

EXXI

Energy XXI

$8.59

-0.41 (-4.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Energy XXI provides operational update on Hurricane Nate impact »

Energy XXI provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial cuts Q4 net interest margin view to up 2-6 bp from 3-9 »

Cuts Q4 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

HGV

Hilton Grand Vacations

$39.83

0.05 (0.13%)

17:45
10/17/17
10/17
17:45
10/17/17
17:45
Hot Stocks
Hilton Grand Vacations acquires Sunrise Lodge, terms not disclosed »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

PRGX

PRGX Global

$6.80

0.05 (0.74%)

, KR

Kroger

$20.48

0.04 (0.20%)

17:42
10/17/17
10/17
17:42
10/17/17
17:42
Hot Stocks
PRGX Global signs multi-year technology services contract with Kroger »

PRGX Global (PRGX) signed…

PRGX

PRGX Global

$6.80

0.05 (0.74%)

KR

Kroger

$20.48

0.04 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 14

    Dec

UBFO

United Security Bank

$9.50

-0.05 (-0.52%)

17:38
10/17/17
10/17
17:38
10/17/17
17:38
Earnings
United Security Bank reports Q3 EPS 16c versus 12c in year-ago period »

Reports Q3 NII $8.2M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

, XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
Xenith Bankshares merger into Union Bankshares receives regulatory approval »

Union Bankshares (UBSH)…

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
OMA Airports reports Q3 terminal passenger traffic up 1.3% »

Aeronautical revenues per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.54

-0.29 (-0.20%)

17:34
10/17/17
10/17
17:34
10/17/17
17:34
Earnings
IBM sees $2.8B-$2.9B increase in Q4 sales from Q3 »

Sees $300M-$400M boost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Earnings
OMA Airports reports Q3 EPS 66c, consensus 70c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

, IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: IBM…

IBM

IBM

$146.54

-0.29 (-0.20%)

IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

SSKN

STRATA Skin Sciences

$1.75

-0.04 (-2.23%)

HCLP

Hi-Crush Partners

$8.95

0.25 (2.87%)

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

NAVI

Navient

$12.20

0.47 (4.01%)

CREE

Cree

$29.34

0.06 (0.20%)

AKTX

Akari Therapeutics

$6.40

-0.08 (-1.23%)

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

FOGO

Fogo De Chao

$12.05

0.1 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 01

    Nov

  • 15

    Nov

  • 18

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
IBM sees increase in gross margin of 2.5 points from Q3 to Q4 »

Says not yet feeling full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

PAYX

Paychex

$62.90

-0.55 (-0.87%)

17:31
10/17/17
10/17
17:31
10/17/17
17:31
Syndicate
Breaking Syndicate news story on Paychex »

Paychex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

VZ

Verizon

$48.40

0.31 (0.64%)

17:24
10/17/17
10/17
17:24
10/17/17
17:24
Hot Stocks
FCC settles New York City E-rate investigation with Verizon »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:20
10/17/17
10/17
17:20
10/17/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:17
10/17/17
10/17
17:17
10/17/17
17:17
Hot Stocks
IBM: Global business services signings up for 3rd consecutive quarter »

Says cognitive solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.